What are the repercussions from the weekend attack on the Aramco refinery. NAB’s Rodrigo Catril suggests prices will be elevated for some time. So who will be the winners and losers?
Antibiotics are failing and pharmaceutical companies aren’t getting the RoI they want to research new strains. Listen to me and @ProfSteveKeen on the false economies of private health.
This is interesting. I wonder who will rate highest in this poll sent to Trump supporters?
It’s been a while since we saw a market reaction to non-farm payrolls, says NAB’s David de Garis, but today’s upside surprise has helped equities rise even higher. https://t.co/mdoQQfpMm4